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ABSTRACT 
Int J Exerc Sci 2(3) :191 -201, 2009. Research indicates that weight cycling, or “yo-yo dieting” is a 
common occurrence in overweight and obese populations.  The long term negative health 
consequences of weight cycling are debated and it is unclear whether or not this weight change 
pattern poses a greater disease risk compared to obesity maintenance.  This review discusses the 
prevalence of weight cycling and physiological alterations occurring during weight loss that 
promotes weight regain.  We also discuss the effect weight regain has upon adipose tissue in 
terms of rate and type of accumulation.  Also within this review are discussions surrounding the 
previously published literature based upon human and rodent research.  We focus on previous 
limitations and difference in experimental design that have perhaps resulted in mixed findings 
concerning independent effects of weight cycling on health parameters.  The final purpose of this 
review is to discuss future directions in evaluating the pro-inflammatory response to weight 
cycling in order to compare the disease risk compared to obesity maintenance.   
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Overview of the Problem 
 
As obesity is becoming increasingly more 
prevalent in the United States, weight loss 
to reduce adipose tissue mass is strongly 
promoted as a means to decrease the 
disease risk associated with excess 
adiposity (5, 57).  Unfortunately, the 
majority of individuals who lose weight are 
unlikely to maintain the reduced weight for 
an extended period of time (15, 51, 59). 
Repeated periods of weight loss and regain 
form a pattern known as weight cycling.  
Hill (2004) indicates that popular and lay 
literature have asserted that weight cycling 
(i.e. “yo-yo dieting”) may increase the risk 
of developing cardiovascular disease or 
type II diabetes to a greater extent than 
remaining weight stable at an obese Body 
Mass Index (BMI; ≥30 kg/m2)(27).  The 
scientific literature is inconsistent regarding 
the long-term consequences of weight 
cycling.  Because there is no universally-
accepted definition of weight cycling, 
differences in experimental design may 
have contributed to discrepancies in 
scientific outcomes.  
 
Weight gain has significant implications 
concerning disease risk, which is believed 
to be mediated by an elevated level of 
systemic inflammation.  Low-grade 
systemic inflammation is associated with 
obesity and it may serve as a link between 
adiposity and the development of 
cardiovascular disease and type 2 diabetes 
(66). To our knowledge, the pro-
inflammatory effects of weight cycling have 
not been examined. Discerning a difference 
in disease risk between maintenance of 
obesity and weight cycling is important and 
may provide insight concerning individual 
differences in disease progression.  If 
weight cycling is associated with an 
increased disease risk, continually 
recommending weight loss to those unable 
to maintain reduced weights may be a 
major public health issue.  This review has 
two aims: 1) to compare studies that both 
support or refute the theory that weight 
cycling is independently associated with 
increases in disease risk2) to discuss the 
possibility that weight cycling impacts pro-
inflammatory biomarkers. 
 
Weight Cycling: A Disruption of Body 
Weight Maintenance? 
 
It has been estimated 24% of American men 
and 38% of women are currently 
attempting to lose weight (35, 53, 64).  
When individuals with an obese BMI are 
considered, 65% of men and 68% of women 
are trying to lose weight, which is a five-
fold increase compared to those within the 
normal BMI (18-24.9 kg/m2) range that are 
trying to lose weight (64).  While successful 
weight loss is achieved, researchers have 
indicated that long-term maintenance of a 
reduced weight appears to be rare.   
 
The probability of weight regain increases 
in the time following initial weight loss 
(43). Researchers believe this is due to the 
energy gap created during caloric 
restriction where decreased energy 
expenditure is paired with an increased 
drive to eat (43).  Rodent studies have 
demonstrated that this gap persists 
regardless of the duration of weight 
reduction, which increases the probability 
of weight regain.(41). This drive to eat 
causes a hyperphagic response when free 
access to food is allowed and when paired 
with suppressed lipid utilization, weight 
regain is often rapid and efficient (41, 43).  
While this finding was elucidated through 
use of a rodent model, human weight 
regain data supports this concept. One year 
after a modest weight loss (14.5% of body 
weight), Votruba et al. (2002) reported that 
within a year of weight loss, 16 out of 28 
women regained weight and had a 19% 
increase in body weight and a 26% increase 
in percent fat mass (59).  Weiss reported 
that by one year after a modest weight loss 
(10% of body weight), 33% of adult subjects 
regained all lost weight.  Furthermore, they 
concluded that the odds of regaining were 
positively associated with the percentage of 
initial weight lost (63).  Field et al. reported 
that approximately 55% of overweight and 
obese women who lost 10% of their body 
weight regained all lost weight within 4 
years (15).  In support of this finding, 
within 9 years of the initial weight loss (5% 
of body weight), 95% of women and 93% of 
men were unable to maintain the reduced 
body weight(51).  Collectively, these studies 
suggest that while initial weight loss is 
possible, long-term maintenance is 
problematic, especially when large amounts 
of weight are lost or an individual is 
overweight or obese. 
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Repeated bouts of weight loss followed by 
regain forms a pattern known as weight 
cycling.  Survey data collected by 
Williamson and colleagues (64) indicated 
that 25% of men and 27% of women trying 
to lose weight have made long-term 
attempts (classified as trying for over 1 year 
or “always trying to lose weight”).  It has 
also been shown that 7% of men and 10% of 
women can be classified as severe weight 
cyclers (intentionally lost at least 5 kg and 
regained at least three different times), 
while 11% of men and 19% of women are 
mild weight cyclers (lost and regained at 
least 5 kg on one or two occasions) (36).  
While these results were generated from a 
group of adults in Finland, the conclusion 
that 18% of men and 27% of women weight 
cycle is comparable to the prevalence 
described by Williamson et al. (64).  These 
numbers are likely a conservative estimate 
of the prevalence of weight cycling, which 
may be even greater in the United States.  
 
Does Weight Regain Disrupt Normal 
Physiology? 
 
The physiological changes associated with 
weight cycling, such as energy expenditure, 
metabolism and fuel utilization, have been 
documented using a rat model. MacLean 
and colleagues (2004) have documented the 
physiological alterations occurring in 
obesity-prone rats that contribute to the 
rapid, efficient regain during relapse 
following weight loss and maintenance.  
Their focus has been on the energy gap 
created during a period of caloric restriction 
that is characterized by decreased energy 
expenditure and an increased drive to eat 
(42).  They found that in addition to 
changes in energy intake, alterations in 
metabolic efficiency and fuel utilization 
(favoring carbohydrate oxidation) may 
significantly affect the propensity to regain 
weight (43).  For instance, in the 16 weeks 
following moderate weight loss (14%), food 
efficiency was increased 10-fold upon the 
first day of a 56-day re-feeding in weight 
cycle rats compared to rats with established 
obesity.  While this dramatic rise was 
reduced within several days, food 
efficiency remained elevated above levels in 
obese mice for the first 4 weeks of relapse 
(41).  The most dramatic changes occurred 
during the first week of relapse, a time 
when nearly 40% of lost weight, which was 
primarily fat mass, was regained (41, 42).  
Researchers also noted that as the length of 
maintenance increased, the amount of 
weight regained upon relapse also 
increased.  Furthermore, regain was 
accompanied by a 30% increase in 
adipocyte concentration per fat pad.  
 
Based on the above literature, it is clear that 
weight gain during relapse appears to 
induce more rapid adipose tissue growth 
and hyperplasia due to metabolic shifts 
favoring lipid storage.  Because adipose 
tissue is a metabolically active tissue, 
responsible for production of leptin, 
cytokines and adiponectin as well as 
responding to traditional hormone 
systems(32), it is possible that the 
consequences of weight gain during relapse 
may also differ from that of initial weight 
gain. In recent years, lay literature has 
asserted that weight cycling may be more 
detrimental to health than simply 
remaining overweight or obese (27, 30). 
Researchers have found associations 
between weight cycling and an overshoot 
of lipogenic enzyme, triglyceride and 
cholesterol levels in animals and increased 
risk of heart attack and stroke in humans (4, 
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16, 34, 52). However, other researchers 
noted no long term adverse effects on body 
composition, blood pressure, lipid profile 
or risk of developing type II diabetes (13, 
22, 37, 49, 56). Due to limited research in the 
area of weight cycling all of the negative 
consequences may not be known.  Existing 
studies differ considerably in their research 
design, subject population used, duration of 
treatment, incorporation of exercise, 
magnitude and frequency of weight cycles.  
The lack of a universal definition of weight 
cycling is perhaps a great contributor to the 
variability within experimental design.  
This variability is discussed in greater detail 
in the following sections.   
 
According to published research, weight 
cycling has been evaluated in one of two 
main ways: using a cross-sectional survey 
model in humans or a longitudinal 
endpoint model in rodents. The next two 
sections highlight research that either 
support or refute the theory that weight 
cycling contributes to detriments in health, 
demonstrating the no definite conclusions 
can be reached at this time. 
 
Longitudinal Endpoint Analysis of 
Weight Cycling: Rodent Models 
 
Utilization of animal experimental models 
allows for more control of subject treatment 
than a human experimental model.  Such 
designs are useful for examining 
mechanisms underlying weight cycling; 
however, care should be taken when 
translating these findings to humans.  An 
increase in internal validity, resulting from 
more control of subject treatments may 
explain why reported conclusions 
regarding weight cycling in animals is a bit 
more consistent than humans. The most 
likely explanation for inconsistent findings 
is due to the manner in which the weight 
cycling response is elicited.   
 
In agreement with the series of studies 
completed by MacLean et al., rapid regain 
occurs during relapse in rats that have been 
on caloric restriction diets (6, 17, 26, 28).  
Weight cycling was associated with 
increased food efficiency (6, 50) and 
increased caloric consumption (26, 52).  
Reed et al. found that despite being at lower 
weights than control rats, weight cycled 
rats were significantly fatter(50).  Ilagan et 
al. reported that weight cycled rats had a 
lower percentage of fat free mass than their 
free fed (high fat diet) counterparts and that 
amount of weight lost during period of 
restriction decreased with each successive 
cycle (28). During re-feeding periods in 
weight cycled rats, researchers have 
consistently reported overshoots in 
lipoprotein lipase, serum triglycerides, and 
serum cholesterol above what has been 
observed in rats that are free-fed a high fat 
diet (17, 34, 52).  It has been speculated that 
body weight overshoot may create a state of 
hyperlipogenesis that may persist for 
several days after re-feeding.  Kim et al. 
demonstrated that fasting serum leptin was 
significantly increased in weight cycled rats 
compared to lean and pair-fed controls 
despite similar quantities of fat mass(33).  
Since leptin concentration is highly 
correlated to the degree of adiposity (11, 
39), further interpretation of this finding 
suggests that weight cycling may induce a 
physiological change in adipocyte release of 
leptin.   
  
In contrast, Brownell et al. did not observe 
alterations in body composition, but this 
could be contributed to an experimental 
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design that only allowed weight cycled rats 
to regain weight until they matched their 
obese controls, even though weight gain 
was still persisting at that time (6).  Also, 
Cleary et al. indicated that weight loss and 
weight regain were linear in nature, 
opposing the “energy gap” theory 
proposed by MacLean et al. that contributes 
to rapid and efficient regain (9, 10).  
However, rats in the Cleary model were fed 
a purified diet rather than a high fat diet; 
the purified diet contained 20.5% high 
nitrogen casein, 50% cornstarch, 5% sucrose 
and 5% corn oil with 9% celufil as a filler 
(9).  Sea et al. demonstrated that re-feeding 
rats a moderate fat (22%) diet yielded 
blunted responses compared to those fed a 
high fat (45%) diet (52).  Furthermore, given 
a choice, weight cycled rats have been 
shown to self-select diets with high fat 
content during re-feeding(50), so perhaps a 
purified diet was not an appropriate 
variable for re-creating the weight cycling 
experience.  Gray et al. stated that the rate 
of each weight loss was not hindered by 
weight cycling(23); however, in this study, 
the first restriction was marked by a 50% 
reduction of intake and the second 
restriction was a 75% reduction, so perhaps 
weight loss would not have been similar 
between weight cycles had the second 
restriction not have been so severe.  Kim et 
al.(33) were not able to demonstrate a 
hyperphagic response, but their use of a 
24hr fast plus 24hr relapse for 21 cycles may 
not have been a design that could show 
effects of weight cycling seen in previously 
mentioned studies; every-other-day 
restriction has lead to other positive 
adaptations (less weight gain, increased 
insulin sensitivity) elsewhere (1).  This may 
indicate that larger weight cycles (increased 
weight loss frequency / magnitude per 
cycle) have differing effects as suggested by 
weight cycling studies in humans.   
 
Cross-sectional Evaluation of Weight 
Cycling: Human Models 
 
Some existing scientific literature supports 
the theory that weight cycling increases 
disease risk (directly or indirectly) in 
humans.  Wallner and colleagues found 
that a history of weight cycling was 
associated with a more pronounced 
android fat distribution in women 
compared to those who were normal-
weight or overweight without a history of 
weight cycling (60).  It is possible that 
women who are prone to the accumulation 
of abdominal adiposity may be more likely 
to weight cycle for a more aesthetically 
desirable figure (48).  Regardless of whether 
weight cycling causes the accumulation of 
android adiposity or vice versa, other 
researchers have found that a history of 
weight cycling was independently 
associated with an increased risk of 
developing hypertension (24) and clinically 
significant decreases in HDL-cholesterol in 
women (47).  French et al(16) and Vergnaud 
et al.(58) demonstrated associations 
between weight cycling and risk for heart 
attack and stroke, as well as the 
development of metabolic syndrome(16, 
58).  Blair et al. studied men enrolled in the 
Multiple Risk Factor Intervention Trial who 
were at elevated risk for coronary heart 
disease due to smoking, hypertension and 
hypercholesterolemia, finding that greater 
weight variability over 4 years of follow up 
was associated to increase all-cause 
mortality(4).   
 
In contrast to the preceding reports, several 
other researchers reported that weight 
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cycling has no independent impact on 
health status.  Prentice et al. found that 
weight cycling did not significantly alter 
body composition (49).  However, unlike 
Wallner et al.(60), who asked for 4 years 
worth of weight history, this study was 
completed in only 18 weeks.  It may be 
possible that any deleterious effects of 
weight cycling do not manifest 
immediately or that the magnitude of the 
weight loss was not sufficient to induce 
long-term change.  Li et al. studied obese 
patients, in a multi-disciplinary weight loss 
program, who had relapsed and re-entered. 
Multiple attempts at weight loss over 12 
years showed no effect on the rate at which 
weight could be lost each time or on blood 
pressure or lipid profile; in fact, these 
measurements at baseline were 
significantly lower at the time of re-entry 
compared to the initial start for men and 
women (37). Initial blood pressure in men 
(134/88 mmHg) and women (126/82 
mmHg) was recorded at the restart baseline 
at 129/85 mmHg and 121/78 mmHg, 
respectively.  While no subjects were 
hypertensive, all values remained within 
the pre-hypertensive range.  Furthermore, 
BP has been documented to fluctuate 
throughout the day (29).  Triglyceride levels 
in men and women were reduced by 0.1 
and 0.2 mmol/L between initial and restart 
baselines and cholesterol was reduced by 
0.1 and 0.5 mmol/L, respectively. Women’s 
values were all within the normal/low risk 
range and men’s values remained in the 
borderline high range.  Cholesterol values 
for both genders were all in the borderline 
high risk range.  While deemed statistically 
significant, the differences between 
baselines may not be physiologically 
relevant as disease risk did not appear to 
change. Even though this study was 
longitudinal in nature, perhaps the use of 
regular exercise as part of the program 
acted as a confounding factor, as aerobic 
exercise is independently and positively 
correlated with decreases in blood pressure 
and cholesterol (19, 25).   
 
A similar exercise effect was reported by 
Field et al. where mild and severe weight 
cycling was strongly associated with weight 
gain and hypertension, controlling the 
statistical analysis for weight and weight 
gain greatly attenuated this correlation(13); 
however, the questionnaire data also 
revealed that severe weight cyclers 
exercised significantly more that non 
weight cyclers.  Graci et al. (2004) noted that 
weight cycling had no effect on 
cardiovascular disease risk factors; weight 
cycling throughout adulthood was not 
associated with changes in body 
composition, fat distribution blood pressure 
or insulin levels(22).  One major difference 
in this study, compared to those with 
competing findings, was that Graci et al.(22) 
used morbidly obese subjects (BMI up to 69 
kg/m2) and perhaps there is a less-
pronounced response to weight cycling in 
this population because the subjects already 
have an elevated disease risk.  Similar 
results by Wing et al. (65) and Jeffery et 
al.(31) may have been effected by the short 
duration of measurement period (2.5 years) 
or the failure to use appropriate blood 
pressure cuffs for obese patients(24).  Field 
et al. concluded that 4 years of weight 
cycling, prior to diagnosis of type 2 
diabetes, was not predictive of disease 
development while Wannamethee et al 
found that weight fluctuation does not 
directly increase risk of death (14, 61).   
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Role of Inflammation in Disease 
Progression: Implications for Weight 
Cycling 
 
When differences in experimental design 
are accounted for, a significant gap in 
scientific knowledge exists concerning the 
exact role of weight cycling in the 
progression of chronic diseases that are 
normally attributed to excess adiposity.  IL-
6 stimulates hepatic release of acute phase 
proteins, including C-Reactive Protein 
(CRP) (3, 66).  Free fatty acids and TNF- α 
act in concert to exacerbate systemic 
inflammation (54).  IL-8, released from 
adipocytes, monocytes and macrophages, 
has been thought to induce chemotaxis 
helping to form atherosclerotic plaques(21).  
IL-6 and TNF-α can act in an autocrine or 
paracrine manner, impairing insulin 
receptor activity and glucose sensitivity in 
adipocytes and muscle tissue (2, 3, 45, 66).  
IL-6 and CRP in circulation target and 
damage arterial endothelial lining; this 
damage helps to initiate or progress 
atherosclerosis (3, 46, 66).  An increase in 
systemic inflammation increases the risk of 
developing a variety of diseases. 
   
Several mechanisms are responsible for the 
pro-inflammatory response in adipose 
tissue due to hypertrophy.  Cytotoxic 
stressors, such as oxidative stress and 
hypoxia, induced by hypertrophy in 
adipose tissue have been reported to trigger 
subsequent pro-inflammatory events (18, 
55).  As cellular stress persists, adipocytes 
secrete IL-6, TNF-α and leptin (38, 55) and 
unless revascularization is adequate, cells 
may become necrotic (44).  The level of 
necrotic adipocyte death is positively 
correlated with increased adiposity and 
concentration of resident macrophages (8).  
Leptin aids in the transmigration of blood 
monocytes into adipose tissue 
compartments, where they mature into 
macrophages (12).  Also, leptin stimulates 
pre-adipocyte stem cells to mature into 
adipocytes or macrophages.  Thus, an 
adiposity driven increase in adipose tissue 
macrophages concentration is a result of 
monocyte influx and directed pre-adipocyte 
transformation (7).  Evidence exists that 
macrophages may be retained longer in 
adipose tissue from obese compared to lean 
subjects (40).  In lean individuals, the 
actions of leptin and granulocyte 
macrophage – colony stimulating factor 
(GM-CSF) are opposed by ghrelin; 
however, reduced ghrelin in obese 
individuals causes deregulation of 
macrophage development in adipose tissue 
(20). Macrophage accumulation has 
significant implications for inflammatory 
disease risk because they are a significant 
source of IL-6, TNF-α, and IL-8 (62, 67). 
 
To our knowledge, there is only one 
published study that examined the effect 
weight variability has on pro-inflammatory 
or related factors.  Yatsuya et al. reported 
that Japanese men with a history of weight 
variability had an independently increased 
odds ratio of elevated CRP (68).  One 
limitation of this study was that it was a 
cross-sectional design thus it was not 
possible to evaluate cause and effect, no 
information on intentionality of weight 
change and the cross-sectional design with 
a majority of subjects having final BMIs less 
than 25 kg/m2.   This lack of literature 
suggests that in order to fully understand 
the possible effects of weight cycling, we 
must include examination of pro-
inflammatory responses to this pattern. 
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Summary 
 
In recent years, lay and popular literature 
has claimed that weight cycling may be 
more detrimental that simply remaining 
overweight or obese.  Scientific research has 
yielded mixed results, but this may be due 
to differences in population used, 
experimental design and method of weight 
cycling.   A current gap in research is the 
pro-inflammatory effect of weight cycling.  .  
Since obesity is so prevalent, weight loss is 
almost universally recommended as 
treatment to reduce disease risk.  But 
because research indicated that relapse is 
likely, it is important to understand if 
weight cycling adds to the current disease 
risk of obesity.  Because weight cycling has 
a distinct effect on adipose tissue and 
adipose tissue is a source of inflammatory 
cytokines, elucidating any increases in 
inflammation beyond that measured in 
sustained obesity may help us to 
understand the independent disease risk 
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